JoVE Logo

登录

需要订阅 JoVE 才能查看此. 登录或开始免费试用。

本文内容

  • 摘要
  • 摘要
  • 引言
  • 研究方案
  • 结果
  • 讨论
  • 披露声明
  • 致谢
  • 材料
  • 参考文献
  • 转载和许可

摘要

Here, we describe a proteomics workflow for characterization of the cell surface proteome of various cell types. This workflow includes cell surface protein enrichment, subsequent sample preparation, analysis using an LC-MS/MS platform, and data processing with specialized software.

摘要

Over the past decade, mass spectrometry-based proteomics has enabled an in-depth characterization of biological systems across a broad array of applications. The cell surface proteome ("surfaceome") in human disease is of significant interest, as plasma membrane proteins are the primary target of most clinically approved therapeutics, as well as a key feature by which to diagnostically distinguish diseased cells from healthy tissues. However, focused characterization of membrane and surface proteins of the cell has remained challenging, primarily due to the complexity of cellular lysates, which mask proteins of interest by other high-abundance proteins. To overcome this technical barrier and accurately define the cell surface proteome of various cell types using mass spectrometry proteomics, it is necessary to enrich the cell lysate for cell surface proteins prior to analysis on the mass spectrometer. This paper presents a detailed workflow for labeling cell surface proteins from cancer cells, enriching these proteins out of the cell lysate, and subsequent sample preparation for mass spectrometry analysis.

引言

Proteins serve as the fundamental units by which the majority of cellular functions are carried out. Characterizing the structure and function of relevant proteins is an essential step to understand biological processes. Over the past decade, advances in mass spectrometry technology, analysis software, and databases have enabled the accurate detection and measurement of proteins at a proteome-wide scale1. Mass spectrometry-based proteomics can be utilized in a diverse array of applications, from basic science analysis of biochemical pathways, to identification of novel drug targets in a translational setting, to diagnosis and monitoring of diseases in the clinic2. When screening for novel drug targets, characterization of the cell surface proteome is particularly important, with over 65% of currently approved human drugs targeting cell surface proteins3. The field of cancer immunotherapy also wholly relies on cancer-specific cell surface antigens to target and specifically eliminate tumor cells4. Mass spectrometry-based proteomics can thus serve as a promising tool to identify new cell surface proteins toward therapeutic interventions.

However, there are several limitations when utilizing conventional proteomics methods to survey tumor cells for novel cell surface protein targets. A primary concern is that surface proteins make up a very small fraction of the total protein molecules in a cell. Therefore, fragments of these proteins are masked by a high abundance of intracellular proteins when performing mass spectrometry analysis of the whole-cell lysate5. This limitation makes it challenging to accurately characterize the cell surface proteome with a traditional proteomics workflow. To address this challenge, it is necessary to develop ways to enrich cell surface proteins out of the whole-cell lysate, prior to analysis on the mass spectrometer. One such method involves the oxidation and biotin labeling of glycosylated cell surface proteins in the intact cells, and subsequent enrichment of these biotinylated proteins from the lysate with a neutravidin pulldown, a process that has been termed "cell surface capture"6. Since ~85% of mammalian cell surface proteins are thought to be glycosylated7, this serves as an effective method of enriching the cell surface proteome out of the whole cell lysate. This paper describes a complete workflow, beginning with cultured cells, of cell surface biotin labeling, and subsequent sample preparation for mass spectrometry analysis (Figure 1). Over several replicates, this method provides robust coverage of the cell surface proteome of a particular sample. Utilizing this method to characterize the cell surface proteome of both tumor and healthy cells can facilitate the discovery of novel cell surface antigens to identify potential immunotherapeutic targets8.

Access restricted. Please log in or start a trial to view this content.

研究方案

NOTE: AMO1 plasmacytoma cells were used for this cell surface proteome experiment. The same protocol could be used for other cell types as well, including a wide array of suspension and adherent cell lines9, as well as various types of primary samples10. However, cell numbers (starting material for the experiment) typically have to be optimized for equivalent proteome coverage. For details related to materials and equipment, see the Table of Materials. For details related to buffers and reagent solutions and their composition, see Table 1.

1. Cell surface labeling with biotin

  1. Count the cultured cells and pellet approximately 3.5 × 107 live cells by centrifugation (5 min at 500 × g, 24 °C).
    NOTE: The AMO1 plasmacytoma cells were passaged with fresh media every 3 days prior to harvesting.
  2. Aspirate the supernatant and resuspend the pellet by adding 1 mL of cold (4 °C) Dulbecco's phosphate-buffered saline (D-PBS) (no calcium, no magnesium), and gently pipetting up and down.
  3. Pellet the cells again (as in step 1.1) and repeat the wash step (step 1.2) once more (two washes in total).
  4. After the second wash, pellet the cells (as in step 1.1) and resuspend them in 990 µL of cold D-PBS by gently pipetting.
  5. Prepare a stock solution of 160 mM sodium metaperiodate (NaIO4) beforehand. Split into 50 µL aliquots and store at -20 °C for up to 6 months. Add 10 µL of 160 mM sodium metaperiodate solution to the cell suspension in step 1.4, mix thoroughly, and incubate on an end-to-end rotor for 20 min at 4 °C.
  6. After the incubation is complete, pellet the cells (as in step 1.1), decant the supernatant, and resuspend in 1 mL of cold D-PBS. Repeat this wash step twice (three washes in total). After the third wash, resuspend the cells in 989 µL of D-PBS.
  7. Prepare a stock solution of 100 mM biocytin hydrazide beforehand. Split into 50 µL aliquots, and store at -20 °C for up to 6 months. Add 1 µL of aniline and 10 µL of 100 mM biocytin hydrazide to the cell suspension in step 1.6, mix thoroughly, and incubate on an end-to-end rotor for 60 min at 4 °C.
  8. After the incubation is complete, pellet the cells (as in step 1.1), decant the supernatant, and resuspend in 1 mL of cold D-PBS. Repeat this wash step twice (three washes in total).
  9. After the third wash, aspirate the supernatant carefully with a pipet, and snap-freeze the cell pellet by placing the tube in liquid N2. Place the frozen pellet at -80 °C, until ready to proceed with lysis and pulldown.

2. Cell lysis and biotin pulldown

  1. Thaw the frozen cell pellet on ice.
  2. Add 500 µL of 2x lysis buffer to the pellet, mix thoroughly, and vortex for 30 s.
    NOTE: Vigorous pipetting and vortexing may be required to fully lyse the pellet. Some insoluble debris (i.e., DNA) is acceptable, as it is removed in the subsequent sonication step.
  3. Sonicate the cell lysate on ice (three bursts, 20 s each, 60% duty cycle).
  4. Centrifuge the lysate to pellet any remaining debris (10 min at 17,200 × g at 4 °C).
  5. While the lysate is centrifuging, add 100 µL of neutravidin agarose resin beads to a filtration column. Attach the column to a vacuum manifold, apply a gentle vacuum, and wash the beads by flowing 3 mL of wash buffer 1 over them.
  6. Remove the filtration column from the vacuum manifold, cap the bottom, and add the clarified cell lysate to the column with the beads. Cap the top of the column, and incubate the lysate with the beads on an end-to-end rotor for 120 min at 4 °C.
    NOTE: When capping the top of the column, firmly hold the bottom cap in place, otherwise it may get dislodged and the cell lysate may leak during incubation.
  7. Prepare wash buffers 1, 2, and 3 (approximately 5 mL of each wash buffer per sample, refer to Table 1), and place them in a 42 °C water bath
  8. After the lysate has finished incubation, place the filtration column back onto the vacuum manifold, apply a gentle vacuum, and wash the beads by flowing 5 mL of wash buffer 1 over them.
    NOTE: More than 5 mL of the wash buffers can be used for washing; extra washing may reduce background, non-specific binding onto the beads.
  9. Repeat the wash step with 5 mL of wash buffer 2.
  10. Repeat the wash step with 5 mL of wash buffer 3.
  11. Once the final wash buffer has flowed entirely through the beads, remove the column from the manifold. Add 100 µL of "Lyse" solution to the beads and transfer them to a 1.7 mL low-protein-binding microcentrifuge tube with a pipet. Briefly spin the tube to settle the beads, and remove 50 µL of the solution without disturbing the settled beads.
    NOTE: The reagents in this step and all subsequent steps use a commercially available proteomics sample preparation kit. The kit provides an optimized, simplified sample preparation workflow. However, these steps can also be performed independent of the kit, using a traditional proteomics workflow as described in Verma et al.9. If the beads remain stuck to the side or bottom of the column, allow the beads that have been transferred to the tube to settle, and use extra "Lyse" solution in the tube to transfer the remaining beads.
  12. Place the tube on a heat block/shaker at 65 °C, and shake at 1,000 rpm for 10 min.
    ​NOTE: This step is required for the reduction and alkylation of cysteine residues prior to digestion.

3. Protein digestion

  1. Resuspend the dried trypsin ("Digest" tube in the kit, stored at -20 °C) by adding 210 µL of the "Resuspend" solution. Pipet the solution up and down several times to ensure all the dried trypsin is resuspended.
  2. After the incubation is complete, add 50 µL of the resuspended trypsin solution to the beads. Incubate the tube at 37 °C, shaking at 500 rpm for at least 90 min to digest the protein.
  3. Once the digestion is complete, transfer the solution containing the beads to a spin column, and insert the column into a 1.7 mL low-protein-binding microcentrifuge tube. Spin the tube (500 × g for 5 min at room temperature [RT]) to separate the digested peptide solution from the beads.
    NOTE: At this stage, PNGase treatment can be performed on the beads once they are separated from the peptide solution, to elute biotinylated peptide fragments from the streptavidin beads. This peptide sample can then be carried forward through the remainder of the workflow as a separate, secondary peptide sample that can be analyzed and compared with the primary sample from on-bead trypsinization. The PNGase approach is likely to provide complementary data to on-bead trypsinization, given the additional specificity for captured N-glycosylated asparagines based on MS-detectable side chain modification12. However, the drawback of this sequential elution approach is the requirement of twice the mass spectrometer instrument time per sample analysis.
  4. Add 100 µL of the "Stop" solution to stop the digestion reaction and acidify the peptide solution.

4. Peptide desalting

  1. Using a tube adapter, place a desalting column in a 1.7 mL low-protein-binding microcentrifuge tube. Add the entire acidified peptide solution to the column. Spin the column (3,800 × g for 3 min) so that the solution flows through the column. The peptides are now bound to the column; discard the flowthrough.
  2. Add 200 µL of "Wash 1" solution to the column and spin (3,800 × g for 3 min, RT). Discard the flowthrough.
  3. Add 200 µL of "Wash 2" solution to the column and spin (3,800 × g for 3 min, RT). Discard the flowthrough.
  4. Transfer the column to a new, labeled 1.7 mL low-protein-binding microcentrifuge tube. Add 100 µL of "Elute" solution to the column and spin (3,800 × g for 3 min, RT). Add another 100 µL of "Elute" solution to the column and spin (3,800 × g for 3 min, RT). The peptides are now eluted off the column into the tube.
  5. Place the peptide solution in a vacuum centrifuge and allow it to dry overnight. Place the dried-down peptides at -80 °C until ready to quantify, and analyze on the mass spectrometer.

5. Peptide resuspension and quantification

  1. Resuspend the dried down peptides in 20 µL of solvent A (0.1% formic acid, 2% acetonitrile).
  2. Centrifuge the resuspended peptides (17,200 × g for 10 min) to pellet any insoluble debris.
  3. Prepare peptide standards for the colorimetric peptide quantification assay.
    1. Place 5 µL of 1,000 mg/mL peptide stock solution in one well of a 96-well plate.
    2. Perform a seven-step serial dilution in the plate with deionized (DI) water, as follows, with 5 µL of each standard per well: 1,000 mg/mL, 500 mg/mL, 250 mg/mL, 125 mg/mL, 62.5 mg/mL, 31.25 mg/mL, and 15.625 mg/mL. Place 5 µL of DI water in an eighth well for the blank.
  4. Place 4 µL of DI water in three separate wells of the 96-well plate. Add 1 µL of the resuspended peptide solution to each well, for a total volume of 5 µL.
    NOTE: When pipetting the peptide solution for quantification, carefully pipet from the top of the solution to prevent disturbing any settled debris.
  5. Calculate how much working reagent is needed (45 µL required per well). Prepare the required volume of the colorimetric assay working reagent; vortex the working reagent to ensure proper mixing of the components.
  6. Add 45 µL of the working reagent to each of the standard and sample wells.
    NOTE: Make the standards in duplicate, and use a multichannel pipet to ensure a minimal difference in the timing of when the reagent is added to the wells.
  7. Cover the plate in aluminum foil and incubate at 37 °C for 15 min.
  8. Analyze the plate on an automated plate reader. Use the absorbance values recorded for the standard samples to generate a linear standard curve. Determine the equation of the standard curve and R2 value. If the R2 value is reasonable (≥0.95), use the standard curve to determine the concentration of resuspended peptides, accounting for the fivefold dilution in the colorimetric assay plate.

6. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis of the digested peptides

  1. Adjust the concentration of the peptide samples to 0.2 µg/µL by adding solvent A, and transfer 10 µL into a 0.6 mL low-protein-binding tube.
  2. Place the tube in the LC autosampler.
  3. Set the LC and MS/MS parameters, according to Figure 2 and Figure 3.
  4. Inject 5 µL (1 µg) of the peptide sample into the LC-MS/MS setup for analysis.
    NOTE: The LC-MS/MS settings shown here are only representative for the illustrations. Depending upon the LC and MS instrument availability, users can modify the settings for the LC gradient and MS/MS parameters to obtain deep proteome coverage. For this paper, the MS data analysis was performed using MaxQuant https://www.maxquant.org/, secondary data analysis was performed using Perseus https://maxquant.net/perseus/, and pathway analysis using https://reactome.org/.

Access restricted. Please log in or start a trial to view this content.

结果

For this experiment, we characterized the cell surface proteome of a tumor cell line by labeling N-glycosylated membrane proteins of intact cells with biotin, and enriching these labeled proteins from the whole cell lysate with a neutravidin pulldown (Figure 1). Further, we performed proteome analysis using LC-MS/MS to characterize enriched cell surface proteins. Unlike whole cell proteome analysis, here, the objective was to characterize only cell surface proteins. Hence, we starte...

Access restricted. Please log in or start a trial to view this content.

讨论

Mass spectrometry-based proteomics is a powerful tool that has enabled unbiased characterization of thousands of unknown proteins on a previously impossible scale. This approach allows us to identify and quantify the proteins, as well as glean a range of insights for the structural and signaling capacities of cells and tissues, by characterizing the variety of proteins present in a particular sample. Moving beyond global protein profiling in a sample, mass spectrometry allows us to characterize various post-translational...

Access restricted. Please log in or start a trial to view this content.

披露声明

The authors declare no competing financial interests.

致谢

We thank Dr. Kamal Mandal (Dept of Laboratory Medicine, UCSF) for help with setting up the LC-MS/MS run, Deeptarup Biswas (BSBE, IIT Bombay) for help with data analysis, and Dr. Audrey Reeves (Dept of Laboratory Medicine, UCSF) for help with data analysis. Related work in the A.P.W. lab is supported by NIH R01 CA226851 and the Chan Zuckerberg Biohub. Figure 1 and Figure 2B were made using BioRender.com.

Access restricted. Please log in or start a trial to view this content.

材料

NameCompanyCatalog NumberComments
Kits
96X iST Sample Preparation KitPreOmicsP.O.00027Proteomics sample preparation kit. Includes reagents for reduction, alkylation, and digestion. Also include desalting columns and reagents. 
Pierce Quantitative Colorimetric Peptide AssayThermo23275Peptide quantification kit. Includes peptide standards and components of working reagents. 
Reagents
AcetonitrileFisherA955-1
Ammonium bicarbonateMillipore Sigma09830-1KG
Biocytin hydrazideBiotium90060
D-PBS (w/o Calcium and Magnesium Salts)UCSF Cell Culture FacilityCCFAL003-225B01
Formic AcidHoneywell94318
Halt Protease and Phosphatase Inhibitor Single-Use CocktailThermo1861280
High Capacity Neutravidin Agarose ResinThermo29204
Phosphate Buffered SalineUCSF Cell Culture FacilityCCFAL001-22J01
RIPA Lysis Buffer, 10xMillipore Sigma20-188
Sodium chlorideFisherBP358-212
Sodium metaperiodateAlfa Aesar13798
Trypan Blue Stain (0.4%)Gibco15250-061
Ultrapure 0.5 M EDTA, pH 8.0Invitrogen15575-038
Urea (Proteomics Grade)VWRM123-1KG
Equipment
TC20 Automated Cell CounterBio-Rad1450102
PrismR MicrocentrifugeLabnet InternationalC2500-R-230V
SonicatorVWRBranson Sonifier 240
Vacuum ManifoldPromegaPromega Vac-Man
Shaking HeatblockEppendorfEppendorf Thermomixer C
End-to-End rotatorLabnetRevolver Adjustable Rotator
LCThermoUltimate 3000 HPLC and UHPLC
Q Exactive Plus Hybrid Quadrapole Orbitrap Mass SpectrometerThermoIQLAAEGAAPFALGMBDK
Microplate ReaderBiotekBiotek Synergy 2 
Vacuum ConcentratorLabconco7810010
Supplies
1.5 mL Protein LoBind TubesEppendorf22431081
1.7 mL Microcentrifuge Tubes
Filtration ColumnsBio-Rad7326008
Spin ColumnsThermo69725

参考文献

  1. Aebersold, R., Mann, M. Mass-spectrometric exploration of proteome structure and function. Nature. 537 (7620), 347-355 (2016).
  2. Aslam, B., Basit, M. B., Nisar, M. A., Khurshid, M., Rasool, M. H. Proteomics: technologies and their applications. Journal of Chromatographic Science. 55 (2), 182-196 (2017).
  3. Bausch-Fluck, D., et al. The in silico human surfaceome. Proceedings of the National Academy of Sciences. 115 (46), 10988-10997 (2018).
  4. Takahashi, Y., et al. Research advance in tumor specific antigens: A narrative review. AME Medical Journal. 6, 35(2021).
  5. Li, Y., Qin, H., Ye, M. An overview on enrichment methods for cell surface proteome profiling. Journal of Separation Science. 43 (1), 292-312 (2020).
  6. Wollscheid, B., et al. Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins. Nature Biotechnology. 27 (4), 378-386 (2009).
  7. Chandler, K. B., Costello, C. C. Glycomics and glycoproteomics of membrane proteins and cell-surface receptors: present trends and future opportunities. Electrophoresis. 37 (11), 1407-1419 (2016).
  8. Ferguson, I. D., et al. The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance. Nature Communications. 13 (1), 4121(2022).
  9. Karcini, A., Lazar, I. M. The SKBR3 cell-membrane proteome reveals telltales of aberrant cancer cell proliferation and targets for precision medicine applications. Scientific Reports. 12 (1), 10847(2022).
  10. Köhnke, T., et al. Integrated multiomic approach for identification of novel immunotherapeutic targets in AML. Biomarker Research. 10 (1), 43(2022).
  11. Verma, A., Kumar, V., Ghantasala, S., Mukherjee, S., Srivastava, S. Comprehensive workflow of mass spectrometry-based shotgun proteomics of tissue samples. Journal of Visualized Experiments. (177), e61786(2021).
  12. Leung, K. K., et al. Broad and thematic remodeling of the surfaceome and glycoproteome on isogenic cells transformed with driving proliferative oncogenes. Proceedings of the National Academy of Sciences. 117 (14), 7764-7775 (2020).
  13. Nix, M. A., et al. Surface proteomics reveals CD72 as a target for in vitro-evolved nanobody-based CAR-T cells in KMT2A/MLL1-rearranged B-ALL. Cancer Discovery. 11 (8), 2032-2049 (2021).
  14. Cox, J., et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. Journal of Proteome Research. 10 (4), 1794-1805 (2011).
  15. Waldman, A. D., Fritz, J. M., Lenardo, M. J. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nature Reviews Immunology. 20 (11), 651-668 (2020).
  16. Hosen, N., et al. The activated conformation of integrin β7 is a novel multiple myeloma-specific target for CAR T cell therapy. Nature Medicine. 23 (12), 1436-1443 (2017).
  17. Costa, A. F., Campos, D., Reis, C. A., Gomes, C. Targeting glycosylation: A new road for cancer drug discovery. Trends in Cancer. 6 (9), 757-766 (2020).
  18. Gundry, R. L., Boheler, K. R., Van Eyk, J. E., Wollscheid, B. A novel role for proteomics in the discovery of cell-surface markers on stem cells: Scratching the surface. Proteomics. Clinical Applications. 2 (6), 892-903 (2008).
  19. Itzhak, D. N., et al. A mass spectrometry-based approach for mapping protein subcellular localization reveals the spatial proteome of mouse primary neurons. Cell Reports. 20 (11), 2706-2718 (2017).
  20. Kirkemo, L. L., et al. Cell-surface tethered promiscuous biotinylators enable comparative small-scale surface proteomic analysis of human extracellular vesicles and cells. eLife. 11, 73982(2022).
  21. Wojtkiewicz, M., Berg Luecke, L., Kelly, M. I., Gundry, R. L. Facile preparation of peptides for mass spectrometry analysis in bottom-up proteomics workflows. Current Protocols. 1 (3), 85(2021).
  22. Välikangas, T., Suomi, T., Elo, L. L. A comprehensive evaluation of popular proteomics software workflows for label-free proteome quantification and imputation. Briefings in Bioinformatics. 19 (6), 1344-1355 (2018).
  23. Cox, J., Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nature Biotechnology. 26 (12), 1367-1372 (2008).
  24. Bausch-Fluck, D., et al. A mass spectrometric-derived cell surface protein atlas. PLoS One. 10 (3), 0121314(2015).
  25. Griss, J., et al. ReactomeGSA-efficient multi-omics comparative pathway analysis. Molecular & Cellular Proteomics. 19 (12), 2115-2125 (2020).
  26. Waas, M., et al. SurfaceGenie: a web-based application for prioritizing cell-type-specific marker candidates. Bioinformatics. 36 (11), 3447-3456 (2020).
  27. Mellacheruvu, D., et al. The CRAPome: a contaminant repository for affinity purification-mass spectrometry data. Nature Methods. 10 (8), 730-736 (2013).
  28. van Oostrum, M., et al. Classification of mouse B cell types using surfaceome proteotype maps. Nature Communications. 10 (1), 5734(2019).
  29. Berg Luecke, L., Gundry, R. L. Assessment of streptavidin bead binding capacity to improve quality of streptavidin-based enrichment studies. Journal of Proteome Research. 20 (2), 1153-1164 (2021).

Access restricted. Please log in or start a trial to view this content.

转载和许可

请求许可使用此 JoVE 文章的文本或图形

请求许可

探索更多文章

Cell Surface CaptureLabel Free QuantificationCell Surface ProteomeMass SpectrometryProteomicsTumor CellsCancer ImmunotherapiesBiotin labeled Cell PelletLysis BufferNeutrAvidin Agarose ResinVacuum ManifoldWash BufferLysate IncubationProtein Binding Microcentrifuge Tube

This article has been published

Video Coming Soon

JoVE Logo

政策

使用条款

隐私

科研

教育

关于 JoVE

版权所属 © 2025 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。